IPG Photonics Corporation
IPGPTechnologyNASDAQSemiconductor Equipment & Materials · Last scanned Oct 23, 2026
Scan Results
Daily timeframeIPG Photonics Corporation develops, manufactures, and sells fiber lasers, fiber amplifiers, diode lasers, and laser-based systems used in materials processing, medical, and advanced applications. The $2.95B market capitalization puts IPGP squarely in mid-cap range for its industry. The company offers laser products, including hybrid fiber-solid state lasers with green and ultraviolet wavelengths; fiber pigtailed packaged diodes and fiber coupled direct diode laser systems; and high-energy pulsed lasers, multi-wavelength and tunable lasers, and single-polarization and single-frequency lasers, as well as other versions.
Market Cap
$2.95B
Beta
0.97
P/E (TTM)
113.79
P/E (Fwd)
30.08
EPS (TTM)
$0.61
EPS (Fwd)
$2.31
ROE
1.3%
ROA
1.0%
Cash
$871.3M
Total Debt
$16.3M
Free CF
$45.3M
52W Change
-19.9%
Annual Financials
Cash vs Debt
Where IPGP stands vs its 150-day and 200-day moving averages
As of the October 15, 2026 close, IPGP finished 26.70% below its 150-day moving average ($100.50) and 27.35% below its 200-day moving average ($101.41). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is IPGP overbought or oversold?
At the October 15, 2026 close, IPGP's RSI(14) was 40.9, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
With $871.3M in cash and $16.3M in debt, IPGP maintains more liquidity than leverage. This favorable balance sheet position can be an asset when capital markets become less accommodating. Free cash flow comes in at $45.3M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. Return on equity stands at 1.3%, which is modest for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 1.0% is on the lower side, which is common in asset-heavy industries. Revenue has pulled back from $1.43B (2022) to $1.00B (2025), a 30% decline worth watching.
With cash comfortably exceeding debt, IPGP has financial flexibility that may help navigate uncertain periods. At over 50x earnings, IPGP carries valuation risk — any slowdown in growth expectations could lead to meaningful price adjustments. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing IPGP.